Mohamed Zaki
Technik-/Wissenschafts-/F&E-Leiter bei ADC THERAPEUTICS SA
Vermögen: 800 332 $ am 31.05.2024
Profil
Mohamed Zaki is currently the Chief Medical Officer at ADC Therapeutics SA. Prior to his current position, he served as the VP & Global Head-Oncology Development at AbbVie, Inc. from 2018 to 2022.
He also held the position of Head-Clinical Development at Centocor, Inc. from 2001 to 2007 and at Sanofi-Aventis U.S.
LLC from 2007 to 2010.
Dr. Zaki holds a doctorate degree from the University of Pennsylvania and graduate and doctorate degrees from Ain Shams University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADC THERAPEUTICS LTD
0,24% | 01.04.2024 | 233 333 ( 0,24% ) | 800 332 $ | 31.05.2024 |
Aktive Positionen von Mohamed Zaki
| Unternehmen | Position | Beginn |
|---|---|---|
| ADC THERAPEUTICS SA | Technik-/Wissenschafts-/F&E-Leiter | 03.01.2023 |
Ehemalige bekannte Positionen von Mohamed Zaki
| Unternehmen | Position | Ende |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01.12.2022 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2007 |
Ausbildung von Mohamed Zaki
| University of Pennsylvania | Doctorate Degree |
| Ain Shams University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ADC THERAPEUTICS SA | Health Technology |
| ABBVIE INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
